Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gabriel

Showing results (191-200 of 347) with videos related to

Pageof 35
Sort By:
Plos One|November 3, 2021
Effects of sustained weight loss on outcomes associated with obesity comorbidities and healthcare resource utilizationG Craig Wood, Lisa Bailey-Davis, Peter Benotti, et al.
ACS Omega|September 9, 2020
New Approach to Dehydration of Xylose to 2-Furfuraldehyde Using a Mesoporous Niobium-Based CatalystJosé B Gabriel, Victor Oliveira, Talita Evelyn de Souza, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Spectrum of somatic mitochondrial mutations in five cancersTatianna C Larman, Steven R DePalma, Angela G Hadjipanayis, et al.
Diabetes, Obesity & Metabolism|September 10, 2025
Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)Kim G Smolderen, Carlos Mena-Hurtado, Zhenxiang Zhao, et al.
European Journal of Human Genetics : EJHG|April 13, 2017
Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panelMario Mitt, Mart Kals, Kalle Pärn, et al.
Nature|January 7, 2014
Discovery and saturation analysis of cancer genes across 21 tumour typesMichael S Lawrence, Petar Stojanov, Craig H Mermel, et al.
American Journal of Preventive Cardiology|June 15, 2026
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE - primary prevention studyKim G Smolderen, Carlos Mena-Hurtado, Victoria Divino, et al.
The American Journal of Cardiology|October 27, 2021
Impact of Sustained Weight Loss on Cardiometabolic OutcomesLisa Bailey-Davis, G Craig Wood, Peter Benotti, et al.
American Journal of Medical Genetics. Part A|May 25, 2013
Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruptionAlex R Paciorkowski, Kim Keppler-Noreuil, Luther Robinson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safetyS Thomas, J D Mendes, S A Souza, et al.
Pageof 35

Showing results (191-200 of 347) with videos related to

Sort By:
Pageof 35
Plos One|November 3, 2021
Effects of sustained weight loss on outcomes associated with obesity comorbidities and healthcare resource utilizationG Craig Wood, Lisa Bailey-Davis, Peter Benotti, et al.
ACS Omega|September 9, 2020
New Approach to Dehydration of Xylose to 2-Furfuraldehyde Using a Mesoporous Niobium-Based CatalystJosé B Gabriel, Victor Oliveira, Talita Evelyn de Souza, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
Spectrum of somatic mitochondrial mutations in five cancersTatianna C Larman, Steven R DePalma, Angela G Hadjipanayis, et al.
Diabetes, Obesity & Metabolism|September 10, 2025
Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)Kim G Smolderen, Carlos Mena-Hurtado, Zhenxiang Zhao, et al.
European Journal of Human Genetics : EJHG|April 13, 2017
Improved imputation accuracy of rare and low-frequency variants using population-specific high-coverage WGS-based imputation reference panelMario Mitt, Mart Kals, Kalle Pärn, et al.
Nature|January 7, 2014
Discovery and saturation analysis of cancer genes across 21 tumour typesMichael S Lawrence, Petar Stojanov, Craig H Mermel, et al.
American Journal of Preventive Cardiology|June 15, 2026
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE - primary prevention studyKim G Smolderen, Carlos Mena-Hurtado, Victoria Divino, et al.
The American Journal of Cardiology|October 27, 2021
Impact of Sustained Weight Loss on Cardiometabolic OutcomesLisa Bailey-Davis, G Craig Wood, Peter Benotti, et al.
American Journal of Medical Genetics. Part A|May 25, 2013
Deletion 16p13.11 uncovers NDE1 mutations on the non-deleted homolog and extends the spectrum of severe microcephaly to include fetal brain disruptionAlex R Paciorkowski, Kim Keppler-Noreuil, Luther Robinson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safetyS Thomas, J D Mendes, S A Souza, et al.
Pageof 35